MUSC Cardiology
J

Controlling Blood Pressure in the Patient with HFpEF

By MUSC Cardiology FEATURING Jan Basile
By MUSC Cardiology FEATURING Jan Basile
1,147 views
October 3, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

02:02
Boehringer Ingelheim and Lilly Cardiology

Overcoming Barriers to HFrEF GDMT Use

Feat. N. Singh

Featured Video

03:03
Boehringer Ingelheim and Lilly Cardiology

The Shift to Rapid Sequencing to Improve Patient Outcomes in HFrEF

Feat. K. Watson

Related Videos

06:38

What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

82.4K views
16:57

Ambulatory Blood Pressure Monitoring

William White

51.2K views
64:45

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

44.9K views
20:48

Cardiac CT in 2023: From Anatomy to Physiology to Plaque Burden and …

Michael Gallagher

30.8K views
10:12

AHA 2022: Chlorthalidone Compared to Hydrochlorothiazide for the Pre…

AHA 2022 Conference Coverage

A. Ishani

28.6K views
11:37

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

22.7K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

21.5K views
28:13

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

20.2K views
27:14

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

14.4K views
13:58

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

12.9K views
15:40

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

13.2K views
18:43

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

12.3K views
26:01

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

9.6K views
27:24

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

8.8K views
17:44

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

8.6K views
45:45

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

8.5K views
12:00

Neurovascular Mechanisms in Female Sexual Arousal Disorders and Pote…

"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.

N. Kim

104 views
10:41

2020 High Blood Pressure Guidelines: When Is BP Too High?

Houston Methodist DeBakey Heart and Vascular Center

A. Marie Navar

8.8K views
33:02

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

5.6K views
09:52

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

7.6K views
AUTOPLAY